Heartfelt gratitude to respected @nsitharaman ji, respected @narendramodi ji, @PMOIndia & @GST_Council for making several life-saving cancer medicines GST-free. 🙏 A special thanks from our @IndiaAlk community for including Alectinib, a crucial therapy for ALK+ #LungCancer patients. 🫁🫶#PatientsFirst #HealthcareForAll #LifeOverTax
Grateful on behalf of hundreds of ALK+ lung cancer patients in India for making Alectinib GST-free. 🙏
A humble request to kindly extend this lifeline by also making Lorlatinib, another life saving ALK therapy, GST-free. @nsitharaman@GST_Council#CancerCare#PatientsVoice
🚨‼️Rising Cancers in Young Adults - India needs to save its demographic dividend! 🇮🇳
🚨 Cancer in India is rising -- especially among young adults, and young women are being disproportionately affected.
Not just breast and cervical cancer, but also lung cancer among non-smoking women. Even for breast and cervical cancer, screening uptake is abysmally low. Why?
Because cancer doesn’t get the “instant drama” of a heart attack caught in a social media reel.
Because too often, oncologists talk only among themselves in medical conferences.
I urge oncologists to join my effort to take this conversation to the highest levels of policy-making.
📊 I have created a short, focused survey (10-15 mins) for oncologists that could directly influence national strategy.
We can only make this happen if you respond.
It’s easy to be cynical. But it’s more important to be part of the solution.
🫱🏽🫲🏽 Oncologists, please take the survey. Share it with peers. Let’s ensure India is ready to face the cancer crisis among its youth.
#CancerAwareness #PublicHealthPolicy #Oncology #WomenInHealth #CancerPrevention #YoungAdults #IndependenceDay #IndependenceDay2025 @docrohatgi@YoungLungCancer@IASLC@Prabhatmalikmd
Tomorrow is #WorldCancerDay..if there's one thing you do -- read this thread & share it with others. Trust me, it will benefit them more than watching the 'viral' reels of 'health influencers'🧵
How is #screening for #LungCancer not mentioned, despite evidence that it saves a similar % of lives as in other cancer types? The reason: India has no screening program for Lung Cancer, and nobody seems to be addressing it.
Isn't it time to change this?
.@TakedaPharma@TakedaOncology I can’t believe you are not providing compassionate access in a geography like India that REALLY needs it! ALK patients from poor families are literally dying for lack of drugs as I write this tweet. Please WAKE UP & show some humanity. These are REAL humans we are talking about, not mere statistics.
@ALKPositiveinc@ALKpositiveINT
.@Pfizer This is a BEYOND EXORBITANT cost for at least 95% of India’s population, if not more! I am myself on Lorlatinib and I KNOW the struggle.
I understand the need to make profits, but should it be at the cost of lives?! Please DO BETTER. @PMOIndia@narendramodi@MoHFW_INDIA@AyushmanNHA
.@pfizer Lorlatinib costs ₹250,000 for 30 tablets in India. Even with patient assistance, ₹125,000/month is beyond reach for most ALK+ patients, & they are dying. Please make Lorlatinib, the only 3rd-gen ALK med, affordable in India—like Crizotinib
@CDSCO_INDIA_INF@PMOIndia
Mrs Devi (46, BPL card holder) from Jammu, or Mrs Kaur (29, house help, mother of a 2-year-old) from Punjab—like many others—can’t access life-saving ALK TKI treatments like #Ceritinib, #Alectinib, and #Lorlatinib due to unaffordable costs, leaving them on the brink. @AyushmanNHA